NEUROTECHNOLOGY MARKET - GROWTH, TRENDS, AND FORECASTS (2025 - 2030)

The Neurotechnology Market Report is Segmented by Product Type (neuroprosthetics, Neurostimulation Devices, Brain-Computer Interfaces, and Other Product Types), Application (neurodegenerative Disorders, Neuropsychiatric Disorders, Chronic Pain Management, and Other Applications), End User (hospitals and Clinics, Research Institutes and Academic Centers, and Other End Users), and Geography (North America, Europe, Asia-Pacific, Middle East & Africa, and South America). The Values of the Mentioned Segments are Provided in USD.

NEUROTECHNOLOGY MARKET - GROWTH, TRENDS, AND FORECASTS (2025 - 2030)

Neurotechnology Market Size

Neurotechnology Market Summary
Study Period 2019 - 2030
Market Size (2025) USD 17.23 Billion
Market Size (2030) USD 32.45 Billion
CAGR (2025 - 2030) 13.50 %
Fastest Growing Market Asia Pacific
Largest Market North America
Market Concentration Medium

Major Players

Neurotechnology Market Major Players

*Disclaimer: Major Players sorted in no particular order

Compare market size and growth of Neurotechnology Market with other markets in Healthcare Industry

Biotechnology

Pharmaceuticals

Healthcare IT

Medical Devices

Animal Health

Device Drug Combination

Neurotechnology Market Analysis

The Neurotechnology Market size is estimated at USD 17.23 billion in 2025, and is expected to reach USD 32.45 billion by 2030, at a CAGR of 13.5% during the forecast period (2025-2030).

The factors that are driving the growth of the neuroelectronics market include the increasing prevalence of neurological disorders, rapid advancements in neuroscience and technology, and the rising demand for improved treatment options.

The rising incidence of neurological disorders, such as Alzheimer's disease, Parkinson's disease, epilepsy, and stroke, has led to a rising demand for effective diagnostic and therapeutic solutions. This situation is projected to drive the growth of the market during the forecast period. According to the Alzheimer’s Association 2024, published in Alzheimer's Disease Facts and Figures, the American population aged 65 years and above has been projected to grow from 58 million in 2021 to 88 million by 2050. As per the same source, an estimated 6.5 million Americans aged 65 years and above are expected to start suffering from Alzheimer’s disease by the end of 2024, and this number is estimated to reach 14 million by the end of 2060.

According to the data published by the National Institute of Neurological Disorders and Stroke in January 2024, Parkinson's disease (PD) is the second-most common neurodegenerative disorder in the United States, which affects around 5%-10% of the geriatric population of the country every year. As per the same source, approximately 500,000 citizens are diagnosed with Parkinson's disease every year.

According to the data published by the WHO in February 2024, more than 50 million people across the world suffer from epilepsy, making it one of the most common neurological diseases. Around 80% of people with epilepsy live in low- and middle-income countries. Estimates suggest that about 70% of people suffering from epilepsy could live seizure-free if they are properly diagnosed and treated. Thus, the rising number of people suffering from Alzheimer's disease, Parkinson's disease, and epilepsy is projected to drive the demand for neurotechnology products to offer new possibilities for early detection, precise diagnosis, and the targeted treatment of these conditions.

The rising number of product launches and approvals is also likely to drive the growth of the market during the forecast period. For instance, in May 2023, Abbott received the FDA's approval for its spinal cord stimulation (SCS) systems for treating chronic back pain in people who cannot undergo back surgery. This kind of back pain is known as non-surgical back pain. This new indication applies to Abbott's SCS in the United States, including the Eterna SCS platform and the Proclaim SCS family. In January 2023, Axonics Inc., a global medical technology company, received the United States Food and Drug Administration's approval for the company's fourth-generation rechargeable sacral neuromodulation system. Thus, the rising number of product approvals is projected to drive the growth of the market by boosting the availability of innovative products and increasing people's confidence in the safety and efficacy of products.

However, the high cost of development and the complex regulatory environment can hinder the growth of the market during the forecast period.

Neurotechnology Industry Overview

The neurotechnology market is semi-consolidated in nature due to the presence of several companies operating globally and regionally. The major players are continuously involved in various strategic activities, such as mergers, acquisitions, and partnerships. The competitive landscape includes a strong presence of local and regional companies that hold market shares and are well known, including Abbott, Boston Scientific, Medtronic, and GE Healthcare.

Neurotechnology Market Leaders

  1. Abbott

  2. Boston Scientific

  3. Medtronic

  4. GE Healthcare

  5. Siemens Healthineers

  6. *Disclaimer: Major Players sorted in no particular order
Neurotechnology Market Concentration
Need More Details on Market Players and Competiters?
Download PDF

Neurotechnology Market News

  • In March 2024, SetPoint Medical, a clinical-stage healthcare company, received a breakthrough device designation from the United States Food and Drug Administration (FDA) for the use of its novel neuroimmune modulation platform for people suffering from relapsing-remitting multiple sclerosis (RRMS).
  • In May 2023, Cognixion, a developer of non-invasive brain-computer interface (BCI) and augmented reality (AR) technology, received the breakthrough device designation for its Cognixion ONE Axon machine.

Neurotechnology Market Report - Table of Contents

1. INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2. RESEARCH METHODOLOGY

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

  • 4.1 Market Overview
  • 4.2 Market Drivers
    • 4.2.1 Rising Prevalence of Neurological Disorders
    • 4.2.2 Surging Advancements in Neuroscience and Technology
    • 4.2.3 Growing Demand for Improved Treatment Options
  • 4.3 Market Restraints
    • 4.3.1 High Cost of Neurotechnology Devices
    • 4.3.2 Stringent Regulatory Framework
  • 4.4 Porter's Five Force Analysis
    • 4.4.1 Threat of New Entrants
    • 4.4.2 Bargaining Power of Buyers/Consumers
    • 4.4.3 Bargaining Power of Suppliers
    • 4.4.4 Threat of Substitute Products
    • 4.4.5 Intensity of Competitive Rivalry

5. MARKET SEGMENTATION (Market Size by Value - USD)

  • 5.1 By Product Type
    • 5.1.1 Neuroprosthetics
    • 5.1.2 Neurostimulation Devices
    • 5.1.3 Brain-Computer Interfaces
    • 5.1.4 Other Products
  • 5.2 By Application
    • 5.2.1 Neurodegenerative Disorders
    • 5.2.2 Neuropsychiatric Disorders
    • 5.2.3 Chronic Pain Management
    • 5.2.4 Other Applications
  • 5.3 By End User
    • 5.3.1 Hospitals and Clinics
    • 5.3.2 Research Institutes and Academic Centers
    • 5.3.3 Other End Users
  • 5.4 Geography
    • 5.4.1 North America
    • 5.4.1.1 United States
    • 5.4.1.2 Canada
    • 5.4.1.3 Mexico
    • 5.4.2 Europe
    • 5.4.2.1 Germany
    • 5.4.2.2 United Kingdom
    • 5.4.2.3 France
    • 5.4.2.4 Italy
    • 5.4.2.5 Spain
    • 5.4.2.6 Rest of Europe
    • 5.4.3 Asia-Pacific
    • 5.4.3.1 China
    • 5.4.3.2 Japan
    • 5.4.3.3 India
    • 5.4.3.4 Australia
    • 5.4.3.5 South Korea
    • 5.4.3.6 Rest of Asia-Pacific
    • 5.4.4 Middle East and Africa
    • 5.4.4.1 GCC
    • 5.4.4.2 South Africa
    • 5.4.4.3 Rest of Middle East and Africa
    • 5.4.5 South America
    • 5.4.5.1 Brazil
    • 5.4.5.2 Argentina
    • 5.4.5.3 Rest of South America

6. COMPETITIVE LANDSCAPE

  • 6.1 Company Profiles
    • 6.1.1 Medtronic
    • 6.1.2 Abbott Laboratories
    • 6.1.3 Boston Scientific
    • 6.1.4 Siemens Healthineers
    • 6.1.5 GE Healthcare
    • 6.1.6 LivaNova PLC
    • 6.1.7 NeuroPace
    • 6.1.8 Neuronetics
    • 6.1.9 Koninklijke Philips N.V.
    • 6.1.10 Elekta AB
  • *List Not Exhaustive

7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies, and Recent Developments
You Can Purchase Parts Of This Report. Check Out Prices For Specific Sections
Get Price Break-up Now

Neurotechnology Industry Segmentation

As per the scope of the report, neurotechnology refers to the interdisciplinary field that combines neuroscience, engineering, and computer science to develop tools, devices, and techniques for understanding, monitoring, and manipulating the nervous system. These technologies encompass a wide range of applications, including brain-computer interfaces, neural prosthetics, neuroimaging, neuromodulation, neuroinformatics, and neurosensing.

Based on the product type, the market is segmented into neuroprosthetics, neurostimulation devices, brain-computer interfaces, and other product types. Based on the application, the market is segmented into neurodegenerative disorders, neuropsychiatric disorders, chronic pain management, and other applications. Based on the end user, the market is segmented into hospitals and clinics, research institutes and academic centers, and other end users. This report also covers the market sizes and forecasts of 17 countries across major regions. For each segment, the market sizing and forecasts have been calculated in terms of USD. 

By Product Type Neuroprosthetics
Neurostimulation Devices
Brain-Computer Interfaces
Other Products
By Application Neurodegenerative Disorders
Neuropsychiatric Disorders
Chronic Pain Management
Other Applications
By End User Hospitals and Clinics
Research Institutes and Academic Centers
Other End Users
Geography North America United States
Canada
Mexico
Europe Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa GCC
South Africa
Rest of Middle East and Africa
South America Brazil
Argentina
Rest of South America
Need A Different Region or Segment?
Customize Now

Neurotechnology Market Research FAQs

How big is the Neurotechnology Market?

The Neurotechnology Market size is expected to reach USD 17.23 billion in 2025 and grow at a CAGR of 13.5% to reach USD 32.45 billion by 2030.

What is the current Neurotechnology Market size?

In 2025, the Neurotechnology Market size is expected to reach USD 17.23 billion.

Who are the key players in Neurotechnology Market?

Abbott, Boston Scientific, Medtronic, GE Healthcare and Siemens Healthineers are the major companies operating in the Neurotechnology Market.

Which is the fastest growing region in Neurotechnology Market?

Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2025-2030).

Which region has the biggest share in Neurotechnology Market?

In 2025, the North America accounts for the largest market share in Neurotechnology Market.

What years does this Neurotechnology Market cover, and what was the market size in 2024?

In 2024, the Neurotechnology Market size was estimated at USD 14.90 billion. The report covers the Neurotechnology Market historical market size for years: 2019, 2020, 2021, 2022, 2023 and 2024. The report also forecasts the Neurotechnology Market size for years: 2025, 2026, 2027, 2028, 2029 and 2030.

Neurotechnology Industry Report

Statistics for the 2025 Neurotechnology market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Neurotechnology analysis includes a market forecast outlook for 2025 to 2030 and historical overview. Get a sample of this industry analysis as a free report PDF download.